Anaesthesia during raised creatine phosphokinase activity.
No adverse effects were observed in a series of patients in whom he levels of creatine phosphokinase (C.P.K.) were known to be raised and who received anaesthetics. The need to exercise caution in the interpretation of screening test results for C.P.K. activity before anaesthesia is stressed.
D000342:Affective Symptoms / Q000628:therapy; D000768:Anesthesia, General; D001285:Atropine / Q000627:therapeutic use; D004796:Clinical Enzyme Tests; D003402:Creatine Kinase / Q000097:blood*; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008305:Malignant Hyperthermia / Q000517:prevention & control; D008403:Mass Screening
D001285:Atropine; D003402:Creatine Kinase